NORDIC MEDICAL SOLUTIONS ApS: Financial statements 2015
CVR: 34352542
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
NORDIC MEDICAL SOLUTIONS ApS (CVR 34352542) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 17,703,010 and a net result of DKK 11,259,050 compared with DKK 3,312,590 the year before. That is an increase of 120.8% compared with the year before. Equity in the 2015 report amounted to DKK 12,009,050. The solvency ratio was 38.1%.
- Gross Profit
- DKK 17,703,010
- Profit/Loss
- DKK 11,259,050
- Equity
- DKK 12,009,050
- Total Assets
- DKK 31,497,908
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 17.7M | 11.3M | 12M | - |
| 2014 | - | 8M | 3.3M | 2.5M | - |
| 2013 | - | 5.5M | 1M | 1.5M | - |
Official annual report
How creditworthy is NORDIC MEDICAL SOLUTIONS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 5, 2015, Christa Bormann has joined the board of directors of NORDIC MEDICAL SOLUTIONS ApS.
As of October 7, 2015, Casper Henrique Tingkær has joined the board of directors of NORDIC MEDICAL SOLUTIONS ApS.
As of October 7, 2015, Kim Erik Ginnerup has joined the board of directors of NORDIC MEDICAL SOLUTIONS ApS.
About NORDIC MEDICAL SOLUTIONS ApS
NORDIC MEDICAL SOLUTIONS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NORDIC PHARMA SOLUTIONS ApS. The management consists of Pernille Wandrup Rex. The board consists of Kim Erik Ginnerup (chair), Monica Reib, Pernille Wandrup Rex and Philip Fischer Stavnstrup. The company is owned by NMS Group A/S. The company has 16 employees (2026). In 2026, the company reported a gross profit of DKK 56,510,150 and a net result of DKK 31,681,814 compared with DKK 28,614,955 the year before. Equity in the 2026 report amounted to DKK 40,681,814.
